APA (7th ed.) Citation

P, G., F, G., S, G., M, C., A, P., L, G., . . . RA, P. (2021). BCL-2 Inhibitor ABT-737 Effectively Targets Leukemia-Initiating Cells with Differential Regulation of Relevant Genes Leading to Extended Survival in a NRAS/BCL-2 Mouse Model of High Risk-Myelodysplastic Syndrome. International journal of molecular sciences, 22(19), . https://doi.org/10.3390/ijms221910658

Chicago Style (17th ed.) Citation

P, Gorombei, et al. "BCL-2 Inhibitor ABT-737 Effectively Targets Leukemia-Initiating Cells with Differential Regulation of Relevant Genes Leading to Extended Survival in a NRAS/BCL-2 Mouse Model of High Risk-Myelodysplastic Syndrome." International Journal of Molecular Sciences 22, no. 19 (2021). https://doi.org/10.3390/ijms221910658.

MLA (9th ed.) Citation

P, Gorombei, et al. "BCL-2 Inhibitor ABT-737 Effectively Targets Leukemia-Initiating Cells with Differential Regulation of Relevant Genes Leading to Extended Survival in a NRAS/BCL-2 Mouse Model of High Risk-Myelodysplastic Syndrome." International Journal of Molecular Sciences, vol. 22, no. 19, 2021, https://doi.org/10.3390/ijms221910658.